ES8802371A1 - Procedimiento para el tratamiento de formas de dosificacion farmaceuticas - Google Patents
Procedimiento para el tratamiento de formas de dosificacion farmaceuticasInfo
- Publication number
- ES8802371A1 ES8802371A1 ES551441A ES551441A ES8802371A1 ES 8802371 A1 ES8802371 A1 ES 8802371A1 ES 551441 A ES551441 A ES 551441A ES 551441 A ES551441 A ES 551441A ES 8802371 A1 ES8802371 A1 ES 8802371A1
- Authority
- ES
- Spain
- Prior art keywords
- dosage forms
- coating
- treating dosage
- treating
- tackiness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2991—Coated
- Y10T428/2998—Coated including synthetic resin or polymer
Abstract
PROCEDIMIENTO PARA EL TRATAMIENTO DE FORMAS DE DOSIFICACION FARMACEUTICAS, EN EL QUE: 1) SE REVISTE UN SUSTRATO QUE CONTIENE DROGA, CON PREFERENCIA UN POLLET, CON UNA FORMULACION DE LIBERACION SOSTENIDA, QUE CONTIENE UN POLIMERO DISPERSABLE EN AGUA Y UN ADSORBENTE; 2) SE REVISTE EL PRODUCTO DE 1) CON UNA SOBRECAPA SOLUBLE EN AGUA QUE CONTIENE UN POLIMERO SOLUBLE EN AGUA Y AL MENOS UN AUXILIAR DE PROCESADO ELEGIDO DEL GRUPO CONSISTENTE EN ADSORBENTES, PLASTIFICANTES Y MEZCLAS DE ELLOS; Y 3) SE RECUPERA LA FORMA DE DOSIFICACION TRATADA EMPLEANDO TECNICAS CONVENCIONALES. LA APLICACION DE LA SEGUNDA SOBRECAPA SE EFECTUA EN EL MISMO DISPOSITIVO UTILIZADO PARA LA CAPA BASE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/696,955 US4600645A (en) | 1985-01-31 | 1985-01-31 | Process for treating dosage forms |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8802371A1 true ES8802371A1 (es) | 1988-05-16 |
ES551441A0 ES551441A0 (es) | 1988-05-16 |
Family
ID=24799186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES551441A Expired ES8802371A1 (es) | 1985-01-31 | 1986-01-30 | Procedimiento para el tratamiento de formas de dosificacion farmaceuticas |
Country Status (17)
Country | Link |
---|---|
US (1) | US4600645A (es) |
JP (1) | JPS61176521A (es) |
AU (1) | AU583582B2 (es) |
BE (1) | BE904136A (es) |
CA (1) | CA1270760A (es) |
CH (1) | CH667008A5 (es) |
DE (1) | DE3601001A1 (es) |
DK (1) | DK45986A (es) |
ES (1) | ES8802371A1 (es) |
FR (1) | FR2576786B1 (es) |
IT (1) | IT1190466B (es) |
LU (1) | LU86274A1 (es) |
NL (1) | NL8600194A (es) |
NZ (1) | NZ214983A (es) |
PH (1) | PH22751A (es) |
SE (1) | SE8600402L (es) |
ZA (1) | ZA86276B (es) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
US4894240A (en) * | 1983-12-22 | 1990-01-16 | Elan Corporation Plc | Controlled absorption diltiazem formulation for once-daily administration |
JPS62103012A (ja) * | 1985-10-23 | 1987-05-13 | Eisai Co Ltd | 多重顆粒 |
JPS62195323A (ja) * | 1986-02-24 | 1987-08-28 | Eisai Co Ltd | 胃内滞留型粒子 |
CA1309022C (en) * | 1986-04-07 | 1992-10-20 | Richard James Harwood | Method for the preparation of a sustained release pharmaceutical composition and the composition prepared thereby |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
US4810501A (en) * | 1986-06-17 | 1989-03-07 | Warner-Lambert Company | Sustained release pharmaceutical preparations |
JPH0774166B2 (ja) * | 1987-02-06 | 1995-08-09 | 信越化学工業株式会社 | 徐放性被覆薬剤の製造方法 |
US5167965A (en) * | 1987-02-09 | 1992-12-01 | The Dow Chemical Company | Palatable cholestyramine granules, tablets and methods for preparation thereof |
US5068110A (en) * | 1987-09-29 | 1991-11-26 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
IL88083A (en) * | 1987-11-06 | 1992-11-15 | Tanabe Seiyaku Co | Controlled release pharmaceutical dosage form and its preparation |
JP2643222B2 (ja) * | 1988-02-03 | 1997-08-20 | エーザイ株式会社 | 多重層顆粒 |
US5019397A (en) * | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
US4960814A (en) * | 1988-06-13 | 1990-10-02 | Eastman Kodak Company | Water-dispersible polymeric compositions |
US5025004A (en) * | 1988-06-13 | 1991-06-18 | Eastman Kodak Company | Water-dispersible polymeric compositions |
NZ233403A (en) * | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
US5084287A (en) * | 1990-03-15 | 1992-01-28 | Warner-Lambert Company | Pharmaceutically useful micropellets with a drug-coated core and controlled-release polymeric coat |
US5098715A (en) * | 1990-12-20 | 1992-03-24 | Burroughs Wellcome Co. | Flavored film-coated tablet |
US5288505A (en) * | 1991-06-26 | 1994-02-22 | Galephar P.R., Inc., Ltd. | Extended release form of diltiazem |
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
US5681585A (en) * | 1991-12-24 | 1997-10-28 | Euro-Celtique, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
US5472712A (en) * | 1991-12-24 | 1995-12-05 | Euroceltique, S.A. | Controlled-release formulations coated with aqueous dispersions of ethylcellulose |
US7070806B2 (en) * | 1992-01-27 | 2006-07-04 | Purdue Pharma Lp | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US20080075781A1 (en) * | 1992-11-25 | 2008-03-27 | Purdue Pharma Lp | Controlled release oxycodone compositions |
US20070275062A1 (en) * | 1993-06-18 | 2007-11-29 | Benjamin Oshlack | Controlled release oxycodone compositions |
US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
US5843480A (en) * | 1994-03-14 | 1998-12-01 | Euro-Celtique, S.A. | Controlled release diamorphine formulation |
US20020006438A1 (en) * | 1998-09-25 | 2002-01-17 | Benjamin Oshlack | Sustained release hydromorphone formulations exhibiting bimodal characteristics |
US5789014A (en) * | 1995-12-25 | 1998-08-04 | Shin-Etsu Chemical Co., Ltd. | Method of manufacturing a solid preparation coated with non-solvent coating |
TW477708B (en) * | 1996-09-13 | 2002-03-01 | Shionogi & Amp Co | Use of the thermal change to produce a substained release preparations and a process for their production |
US6306438B1 (en) | 1997-07-02 | 2001-10-23 | Euro-Celtique, S.A. | Stabilized sustained release tramadol formulations |
US6197347B1 (en) | 1998-06-29 | 2001-03-06 | Andrx Pharmaceuticals, Inc. | Oral dosage for the controlled release of analgesic |
US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
KR101476574B1 (ko) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
MXPA03003895A (es) | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada. |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
BR0312876A (pt) * | 2002-07-25 | 2005-06-28 | Pharmacia Corp | Método de preparação de formas de dosagem sólidas revestidas em duas camadas compreendendo um polìmero insolúvel em água e um agente formador de poros solúvel em água |
JP4767492B2 (ja) * | 2003-12-25 | 2011-09-07 | ライオン株式会社 | 高分子被覆粒子の製造方法、高分子被覆粒子、並びにこれを用いた圧縮成形品 |
US7829148B2 (en) * | 2006-02-07 | 2010-11-09 | Fmc Corporation | Coating process to produce controlled release coatings |
EP2018160B1 (en) | 2006-03-16 | 2011-12-14 | Tris Pharma, Inc. | Modified release formulations containing drug-ion exchange resin complexes |
EP2068840A2 (en) * | 2006-07-21 | 2009-06-17 | LAB International SRL | Hydrophobic abuse deterrent delivery system |
US20100069887A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Multiple chamber ex vivo adjustable-release final dosage form |
US20100068153A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo activatable final dosage form |
US20100068235A1 (en) * | 2008-09-16 | 2010-03-18 | Searete LLC, a limited liability corporation of Deleware | Individualizable dosage form |
US8753677B2 (en) * | 2008-09-16 | 2014-06-17 | The Invention Science Fund I, Llc | Ex vivo modifiable multiple medicament final dosage form |
US20100068275A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Personalizable dosage form |
US20100068152A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable particle or polymeric based final dosage form |
US20100069821A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Ex vivo modifiable medicament release-sites final dosage form |
US20100068254A1 (en) * | 2008-09-16 | 2010-03-18 | Mahalaxmi Gita Bangera | Modifying a medicament availability state of a final dosage form |
US20100068233A1 (en) * | 2008-09-16 | 2010-03-18 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Modifiable dosage form |
WO2013003622A1 (en) | 2011-06-28 | 2013-01-03 | Neos Therapeutics, Lp | Dosage forms for oral administration and methods of treatment using the same |
EP2790729A4 (en) * | 2011-12-12 | 2015-08-12 | Orbis Biosciences Inc | PARTICULATE FORMULATIONS WITH DELAYED RELEASE |
BR112015003120B1 (pt) | 2012-08-15 | 2022-08-09 | Tris Pharma , Inc | Tablete mastigável de liberação estendida de metilfenidato e seu uso |
CA3018328A1 (en) | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3173839A (en) * | 1962-01-09 | 1965-03-16 | Smith Kline French Lab | Method of printing pharmaceutical forms |
US3935326A (en) * | 1967-06-28 | 1976-01-27 | Boehringer Mannheim G.M.B.H. | Process for coating tablets with aqueous resin dispersions |
US3909444A (en) * | 1971-08-05 | 1975-09-30 | Ncr Co | Microcapsule |
DE2522483C2 (de) * | 1975-05-21 | 1984-06-28 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von lackierten Tabletten |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
JPS54105223A (en) * | 1977-12-29 | 1979-08-18 | Yamanouchi Pharmaceut Co Ltd | Coating agent for solid medicine |
JPS5535031A (en) * | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
JPS5598120A (en) * | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
US4248856A (en) * | 1979-07-10 | 1981-02-03 | American Home Products Corporation | Sustained release pharmaceutical compositions |
CH649216A5 (de) * | 1979-08-16 | 1985-05-15 | Sandoz Ag | Verfahren zur auftragung eines magensaftresistenten filmes auf einen heilmittelkern und feste einheitsdosierungsform mit magensaftresistentem film. |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
JPS5855125B2 (ja) * | 1980-03-10 | 1983-12-08 | 信越化学工業株式会社 | 固形薬剤用腸溶性コ−テイング剤組成物 |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
EP0052075A1 (de) * | 1980-11-12 | 1982-05-19 | Ciba-Geigy Ag | Körnige Arzneimittel-Retardform |
IT1153487B (it) * | 1982-04-15 | 1987-01-14 | Prophin Lab Spa | Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli |
-
1985
- 1985-01-31 US US06/696,955 patent/US4600645A/en not_active Expired - Fee Related
-
1986
- 1986-01-14 ZA ZA86276A patent/ZA86276B/xx unknown
- 1986-01-15 DE DE19863601001 patent/DE3601001A1/de not_active Withdrawn
- 1986-01-22 AU AU52619/86A patent/AU583582B2/en not_active Ceased
- 1986-01-23 FR FR868600927A patent/FR2576786B1/fr not_active Expired
- 1986-01-24 CA CA000500319A patent/CA1270760A/en not_active Expired - Fee Related
- 1986-01-28 NL NL8600194A patent/NL8600194A/nl not_active Application Discontinuation
- 1986-01-28 LU LU86274A patent/LU86274A1/fr unknown
- 1986-01-28 PH PH33339A patent/PH22751A/en unknown
- 1986-01-29 BE BE6/48185A patent/BE904136A/fr not_active IP Right Cessation
- 1986-01-30 NZ NZ214983A patent/NZ214983A/en unknown
- 1986-01-30 ES ES551441A patent/ES8802371A1/es not_active Expired
- 1986-01-30 DK DK45986A patent/DK45986A/da not_active Application Discontinuation
- 1986-01-30 SE SE8600402A patent/SE8600402L/ not_active Application Discontinuation
- 1986-01-30 CH CH358/86A patent/CH667008A5/fr not_active IP Right Cessation
- 1986-01-30 JP JP61016992A patent/JPS61176521A/ja active Pending
- 1986-01-30 IT IT47603/86A patent/IT1190466B/it active
Also Published As
Publication number | Publication date |
---|---|
LU86274A1 (fr) | 1986-06-09 |
DE3601001A1 (de) | 1986-08-07 |
IT8647603A0 (it) | 1986-01-30 |
CA1270760A (en) | 1990-06-26 |
SE8600402L (sv) | 1986-08-01 |
CH667008A5 (fr) | 1988-09-15 |
ZA86276B (en) | 1986-08-27 |
IT1190466B (it) | 1988-02-16 |
DK45986D0 (da) | 1986-01-30 |
DK45986A (da) | 1986-08-01 |
JPS61176521A (ja) | 1986-08-08 |
BE904136A (fr) | 1986-07-29 |
ES551441A0 (es) | 1988-05-16 |
SE8600402D0 (sv) | 1986-01-30 |
PH22751A (en) | 1988-11-28 |
FR2576786A1 (fr) | 1986-08-08 |
AU583582B2 (en) | 1989-05-04 |
NZ214983A (en) | 1988-02-29 |
FR2576786B1 (fr) | 1989-05-26 |
AU5261986A (en) | 1986-08-07 |
US4600645A (en) | 1986-07-15 |
NL8600194A (nl) | 1986-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8802371A1 (es) | Procedimiento para el tratamiento de formas de dosificacion farmaceuticas | |
ES2003139A6 (es) | Procedimiento para preparar perlas para la obtencion de productos de liberacion controlada de farmacos. | |
DE69334132D1 (de) | Raloxifene in der Behandlung von postmeopausal Osteoporose | |
EP0243498A4 (en) | DETACHABLE COATING FILM AND COATING METHOD USING THE SAME. | |
DE3874360D1 (de) | Kugelfoermige granula mit kern sowie deren herstellung. | |
EP0339811A3 (en) | Aqueous based pharmaceutical coating composition for dosage forms | |
NO863997D0 (no) | Fremgangsmaate for fremstilling av et farmasoeytisk preparat | |
SE7906119L (sv) | Lekemedel-retardform med olosliga porosa diffusionsholjen | |
SE9403346D0 (sv) | Metod och anordning för framställning av dental produkt samt produkt framställd av metoden och anordningen | |
EP0171528A3 (en) | Controlled release pharmaceutical preparations | |
DE59305700D1 (de) | Verfahren zur Herstellung von festen pharmazeutischen Retardformen | |
EP0160501A3 (en) | Sustained release intranasal formulation and method of use thereof | |
AU6857887A (en) | Therapeutic agent | |
JPS52139715A (en) | Coated granules of alkali polyacrylate | |
DE3573884D1 (en) | Substained release tablets and method for preparation thereof | |
JPS5234935A (en) | Medicinal composition | |
ES8800844A1 (es) | Procedimiento para disgregar polen de flores. | |
CA2051369A1 (en) | Thyroid hormone cardiac treatment | |
ZA902352B (en) | Phytosanitary composition,its process of preparation and its use for treating cryptogamic diseases | |
CS632787A2 (en) | Device for heat treatment,esp. drying of leather and similar materials | |
ZA898921B (en) | 2-azabicyclo(2.2.1)herp-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine | |
EP0270682A4 (en) | NEW COMPLEXES, PROCESS FOR THEIR PREPARATION, AND THEIR MEDICINAL USE. | |
JPS649205A (en) | Fixer composition, organic polymer for fixer, coating supporter and manufacture | |
EP0317882A3 (en) | Fluor containing compounds based on 4,4-bisû2-(4-hydroxy-phenyl)hexafluorisopropyl¨diphenylether, process for their preparation and use | |
ATE62409T1 (de) | Neue arzneimittelzubereitung mit geregelter verabreichung des aktiven mittels, und deren herstellungsverfahren. |